On November 3, 2020, Enzon Pharmaceuticals, Inc. has filed a definitive proxy statement soliciting proxies and urged the shareholders to vote for elect its director nominees; Jordan Bleznick, Jennifer McNealey, and Randolph C. Read to its board at its annual general meeting of shareholders scheduled to be held on December 18, 2020.